Lee, K., Chung, H., Kim, W. S., Chow, L., Lakhani, N., Messersmith, W., Bang, Y., LoRusso, P., Fanning, P., Squifflet, P., Jin, F., Forgie, A., Wan, H., Pons, J., Randolph, S., & Gainor, J. (n.d.). 404 ALX148, a CD47 blocker, in combination with standard chemotherapy and antibody regimens in patients with gastric/gastroesophageal junction (GC) cancer and head and neck squamous cell carcinoma (HNSCC). Journal for immunotherapy of cancer, 8, A245–A246. http://access.bl.uk/ark:/81055/vdc_100144719908.0x000006